Bladder Cancer Progression Despite BCG Therapy Predicts Worse Outcomes
Patients who progress on bacillus Calmette-Guérin (BCG) therapy to muscle-invasive bladder cancer (MIBC) have worse outcomes than patients with de novo MIBC and warrant neoadjuvant chemotherapy (NAC), according to investigators. In a review of 801…